David William Rasnick
David Rasnick holds bachelor’s degrees in biology and chemistry and a Ph.D. in chemistry from the Georgia Institute of Technology. In 1978, he was one of two Ph.D. scientists hired by Abbott Laboratories to help establish the chemistry group in its Diagnostics Division in North Chicago, Illinois.
After leaving Abbott in 1980, Rasnick founded four biotech startups. For nearly two decades, he developed enzyme inhibitors related to tissue destruction caused by arthritis, emphysema, parasites, and cancer.
In 1996, he left the pharmaceutical and biotech industry to work with Professor Peter Duesberg at the University of California, Berkeley, focusing on cancer research and AIDS. Duesberg and Rasnick published extensively on both subjects and advanced Theodor Boveri’s century-old chromosomal imbalance theory of cancer.
In 2012, Rasnick published The Chromosomal Imbalance Theory of Cancer: Autocatalyzed Progression of Aneuploidy is Carcinogenesis for cancer researchers. His new book, The Outsider’s Advantage: A Personal Odyssey into the Essence of Cancer, tells the same story in plain language while tracing Rasnick’s decades-long journey as a scientific outsider.
More of his work can be found at www.davidrasnick.com.
